Status:
COMPLETED
IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Ehlers-Danlos Syndrome, Classic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators want to inject insulin-like growth factor-I (IGF-I) into the patella tendon of Ehlers-Danlos patients and healthy controls to evaluate the response in collagen synthesis. Furthermore...
Detailed Description
IGF-I will be injected with ultrasound guidance to one patella tendon and the other one will be injected with saline as control. Injections will be performed double blinded and timed 24 hours and 6 ho...
Eligibility Criteria
Inclusion
- Classic form of Ehlers-Danlos syndrome OR healthy matched control
Exclusion
- Malignity, cardiac diseases, diabetes, tendinopathy in patella tendons
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01446783
Start Date
September 1 2011
End Date
November 1 2012
Last Update
November 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Sportsmedicine Copenhagen
Copenhagen, Denmark, 2400